Our research spans a number of areas, primarily related to the collection of patient-reported outcomes in elective surgeries.
PROs in the news
- Cabozantinib Plus Nivolumab and Ipilimumab Elicits Meaningful ... - OncLive
- Dr Cohen on Teclistamab Plus Talquetamab in R/R Multiple Myeloma - OncLive
- An App Improved Anxiety, Depression Symptoms in Patients With ... - Curetoday.com
- Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial - Yahoo Finance
- First-in-Class Sjogren's Drug Passes Mid-Stage Test - Medpage Today